Group 1: Company Developments - Hengqin Bihua Medical Laboratory successfully passed the ISO15189 accreditation site review, indicating that its quality management system and testing capabilities meet international standards [5] - Zhenjiankang Company received NMPA Class III medical device registration for two innovative products, bringing its total to seven Class III and four Class II medical device registrations [6] - Guangdong Taiwen Biological Engineering Co., Ltd. obtained a Class II medical device production license, marking compliance with national regulatory requirements in the field of in vitro diagnostic reagents [7] Group 2: Industry Initiatives - The dual-currency payment pilot program has expanded to six key commercial areas in Hengqin, facilitating small payments in both RMB and MOP, enhancing consumer experience [8] - The revised management measures for the Hengqin Guangdong-Macao Deep Cooperation Zone government investment fund were published, effective from August 13, 2025, focusing on key industry projects [9] - The newly issued support measures for financing development of small and micro enterprises in Hengqin include interest subsidies and risk compensation, with a maximum single financing risk compensation of 7.2 million yuan [10][11]